+1 249-493-6904
CPQ Cancer
[cancerscience@cientperiodique.online] Special Submissions to COVID Issue
Category: Gold Open Access Indexing Sites: Google Scholar, Click to view PublonsClick to view Current Issue: Volume 3 Issue 2
Honourable Reviewers of Current Articles: Dr. Emeka Taye Umezurike, Dr. Tarek Mohamed Kamal Motawi, Dr. Erisa Kola, Dr. Sicong Zhang, Dr. Giulio Tarro & Dr. Chrow Khurshid
Cancers are often managed through technological advancements with the help of multi-disciplinary cancer conferences where medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patient. Valuable, important updates on behalf of oncologists with respect to the latest advancements in oncology, enables the management of cancer. Clinical trials in respective aspects are very essential for all the patients in whom cancer progresses and for whom no standard of care treatment options are available. In certain circumstances, an oncologist can mean the difference between life and death.
Cancer research enables to identify the causes and to develop strategies for prevention, diagnosis, treatment, and also to improve the performance of clinical trials to evaluate and compare the applications of various cancer treatments.
Journal Features
- Immediate response towards the articles received.
- Accepts papers from all areas of Cancer.
- Providing rapid update regarding articles.
- Presence of pertinent Editors and Reviewers.
- Prompt peer review and decisions upon papers.
- Comprehensive review through Editors and Reviewers with proficiency in the associated field.
- Comfortable online and e-mail submission.
- Fair decision making and ethics to ensure every decision is fair and transparent.
- Grant of publication certificate to the authors.
- “Best Article of Issue” certificate after each issue release.
Aim and Scope
Subject areas include, but are not restricted to the following fields:
Anticancer Agents, Apoptosis, Biomarkers & Treatment, Cancer Biology, Cancer Informatics, Cancer related Ethics, Cancer Toxicology, Carcinogenesis, Cell, Molecular & Stem Cell Biology, Cellular Oncology, Diagnostics, Drug Discovery & Delivery, Epidemiology & Prevention, Epidemiology and Cancer Prevention, Genetics and Epigenetics, Genetics, Genomics & Proteomics, Immunotherapy, Inflammation & Virology, Kaposi Sarcoma, Leukaemia, Metabolism, Molecular Cancer, Mutagenesis, Myeloma Cells, Oncogenes, Pathology, Predictive Markers, Radiation Oncology, Resistance and Metastasis, Tumour Microenvironment, Tumour Necrosis.
The desire of CPQ Cancer is to publish articles in all related aspects.
Latest Articles
Psychosocial Needs and Improved Quality of Life among Cancer Patients Receiving Palliative Care
Cancer disease is a threat to individual life. Patients with cancer experience varied degrees of physical and emotional distress from various issues and drought of desirable psychosocial needs. The purpose of this study was to investigate the relationship between psychosocial needs and quality of life (QOL) [...] READ MORE
Anthracycline-Based Combination Chemotherapy (Doxorubicin and Dacarbazine) For the Desmoid Tumor in a Neoadjuvant Setting. Report of a Case
We report a case of a 41-year-old female with a sporadic abdominal wall desmoid tumor. After a period of 12-month observation, chemotherapy was given with Doxorubicin and Dacarbazine to facilitate minimal surgery. The patient received 4 cycles of chemotherapy. Treatment was well tolerated and resulted in a significant reduction of the tumor size from 48mm to 25mm, 48% reduction. [...] READ MORE
Visualization of an Intra-Operative X-Ray Source With Liquid Scintillation Imaging
Intraoperative radiotherapy (IORT) is an alternative to full course radiotherapy for select patients. The IntraBeam (Zeiss, Germany) delivery system uses a low energy (50kVp) x-ray source. In this communication, a method for rapidly characterizing emissions from an IORT x-ray source is shared. A leaded glass phantom was filled with liquid scintillation cocktail (LSC) (Ultima Gold; PerkinElmer, USA) and a 13 MP CMOS detector used to collect images and videos. [...] READ MORE
COVID-19 and the Severity of the Disease in Different Types of Cancer
Italy, Spain and the USA suffered the most in the early stages of the world wide outbreak of COVID-19 and subsequently the World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic on 12 March 2020. Cancer patients with comorbidities (hypertension, diabetes and cardiorenovascular diseases) can lead to severe illness and death as cancer patients have a higher risk of severe illness and death than COVID-19 patients without cancer. [...] READ MORE
COVID-19 and Cancer Review: Surgical Oncology, Telemedicine, and Mental Health
Due to the spread of COVID-19, many medical institutions began to cancel/postpone elective procedures out of concerns for safety. The American College of Surgeons (ACS) and the Centers for Disease Control and Prevention (CDC) recommended cancelling or postponing non-emergent surgeries since March 2020 [1]. [...] READ MORE
When Ribosomal Protein Go Bad-Mutation of Ribosomal Protein RPS23 in Different Diseases
Ribosomal protein (RP) gene mutations, mostly are associated with inherited or acquired bone marrow failure; it is believed that RP to drive disease by slowing the rate of protein synthesis. Ribosomes, are responsible for protein synthesis; ribosome, consist of a small 40S subunit and a large 60S subunit. [...] READ MORE
Immunotherapy in Colorectal Cancer: A Promising Avenue?
Advancements in immunotherapy, particularly immune checkpoint inhibitors, have revolutionized the treatment of metastatic colorectal cancer (mCRC). However, the efficacy of available immunotherapeutic agents is largely limited to tumors with DNA mismatch repair-deficient (dMMR) and/or those with microsatellite instability-high (MSI-H) mCRC. [...] READ MORE
Effect of the COVID-19 Pandemic on Cancer Treatment
Since being identified as a public health emergency of major international concern, the outbreak of coronavirus disease (COVID-19) in 2019 has rapidly spread globally and has now been declared a pandemic by the World Health Organization (WHO). COVID- 19 has the characteristics of rapid spread from person to person. Many cancer patients often go to the hospital for treatment and disease monitoring. [...] READ MORE
The Impact of COVID-19 on Cancer Care and Research
No one predicted what the impact of COVID-19 upon globe would have been. The impact has been devastating, from a humanistic as well as from healthcare perspective. However, I am constantly reminded that no matter where the final numbers tally out to with respect to the human tragedy, COVID-19 thus far is not even close to the Great Flu Epidemic in 1917 during World War I. [...] READ MORE
A Novel Bioinformatic Approach for Large Deletion Detection in Multiplex Pcr-Based Ngs Assays
Background
Next-generation sequencing (NGS) has changed genetic diagnostics due to its high throughput, speed, and cost-effectiveness. This paper describes the challenges that were faced in detection of the frameshift variant c.1175_1214del in the BRCA1 gene, undetectable by CNV analysis, using Oncomine BRCA Research Assay (OBRA) and Ion Torrent platform. [...] READ MORE
Total Articles Published
8
9
2
